2-158807105-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001017920.3(DAPL1):c.197C>A(p.Ala66Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000176 in 1,609,630 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A66T) has been classified as Likely benign.
Frequency
Consequence
NM_001017920.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DAPL1 | NM_001017920.3 | c.197C>A | p.Ala66Glu | missense_variant | 3/4 | ENST00000309950.8 | NP_001017920.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DAPL1 | ENST00000309950.8 | c.197C>A | p.Ala66Glu | missense_variant | 3/4 | 1 | NM_001017920.3 | ENSP00000309538.4 | ||
DAPL1 | ENST00000621326.4 | c.197C>A | p.Ala66Glu | missense_variant | 3/5 | 1 | ENSP00000479872.1 | |||
DAPL1 | ENST00000343761.4 | c.122C>A | p.Ala41Glu | missense_variant | 2/4 | 3 | ENSP00000385306.2 | |||
DAPL1 | ENST00000409042.5 | c.197C>A | p.Ala66Glu | missense_variant | 3/5 | 4 | ENSP00000386422.1 |
Frequencies
GnomAD3 genomes AF: 0.000131 AC: 20AN: 152166Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000172 AC: 43AN: 250108Hom.: 0 AF XY: 0.000207 AC XY: 28AN XY: 135212
GnomAD4 exome AF: 0.000181 AC: 264AN: 1457346Hom.: 0 Cov.: 31 AF XY: 0.000207 AC XY: 150AN XY: 725098
GnomAD4 genome AF: 0.000131 AC: 20AN: 152284Hom.: 0 Cov.: 32 AF XY: 0.000148 AC XY: 11AN XY: 74466
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 13, 2021 | The c.197C>A (p.A66E) alteration is located in exon 3 (coding exon 3) of the DAPL1 gene. This alteration results from a C to A substitution at nucleotide position 197, causing the alanine (A) at amino acid position 66 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at